LINC02203

Across TCGA pan-cancer cohorts, LINC02203 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC02203 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02203 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02203 expression acts as an unfavorable survival marker, although some lineages such as LGG and LUSC show a favorable association.

COAD, OV, and CESC are the cancer types where LINC02203 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.188	0.786	<.001	189	view →
OV	DFS	Tertile	All	0.235	0.390	.001	72	view →
CESC	OS	Tertile	III,IV	0.091	0.755	<.001	72	view →
THCA	OS	Tertile	III,IV	0.133	0.947	<.001	63	view →
LGG	DFS	Median	All	0.824	0.668	<.001	48	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
KIRP	DFS	Tertile	III,IV	0.519	0.703	.001	27	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
LUSC	OS	Tertile	All	0.822	0.642	.020	18	view →
KIRC	DFS	Tertile	All	0.232	0.630	.040	12	view →
LIHC	DFS	Tertile	III,IV	0.551	0.136	.010	12	view →
KICH	OS	Tertile	All	0.589	0.938	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC02203–COAD (DFS)

Open the COAD breakdown →